Cancer biotherapy & radiopharmaceuticals
Mar 28, 2025
This review examined multiple deep learning (DL) methods, including artificial neural networks (ANNs), convolutional neural networks (CNNs), k-nearest neighbors (KNNs), as well as generative adversarial networks (GANs), relying on their abilities to...
Cancer biotherapy & radiopharmaceuticals
Feb 20, 2025
Deep learning artificial intelligence (AI) algorithms are poised to subsume diagnostic imaging specialists in radiology and nuclear medicine, where radiomics can consistently outperform human analysis and reporting capability, and do it faster, with ...
Cancer biotherapy & radiopharmaceuticals
Nov 5, 2024
Reporting of diagnostic nuclear images in clinical cancer management is generally qualitative. Theranostic treatment with Lu radioligands for prostate cancer and neuroendocrine tumors is routinely given as the same arbitrary fixed administered activi...
Cancer biotherapy & radiopharmaceuticals
Oct 18, 2024
Bone metastasis (BM) is a serious clinical symptom of advanced colorectal cancer. However, there is a lack of effective biomarkers for early diagnosis and treatment. RNA-seq data from public databases (GSE49355, GSE101607) were collected and normal...